Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
39.62
+0.19 (0.48%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees increased by 58 or 21.97% compared to the previous year.
Employees
322
Change (1Y)
58
Growth (1Y)
21.97%
Revenue / Employee
$1,046,236
Profits / Employee
-$273,112
Market Cap
1.94B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
MIRM News
- 9 days ago - Mirum's LIVMARLI Now FDA Approved in Tablet Formulation - Business Wire
- 13 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - LIVMARLI Now Approved in Japan for ALGS and PFIC - Business Wire
- 4 weeks ago - Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call - Seeking Alpha
- 2 months ago - Mirum Pharmaceuticals, Inc. (MIRM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update - Business Wire
- 2 months ago - Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) - Business Wire
- 2 months ago - US FDA approves Mirum Pharma's genetic disorder drug - Reuters